Marc Hansen

Marc hansen

Marc Hansen

Dr. Marc Hansen is a small molecule and early drug development expert. He is the Founder and Chief Executive Officer of Frost Biologic, an oncology pharmaceutical company with over $2M in funds raised. They are planning to move their lead program, Frost 450, into clinical trials in mid-2016. Dr. Hansen received his PhD of Cancer Biology from Stanford University.